These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17174368)

  • 1. Drug resistance in tuberculosis--a reinfection model.
    Rodrigues P; Gomes MG; Rebelo C
    Theor Popul Biol; 2007 Mar; 71(2):196-212. PubMed ID: 17174368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-drug resistant tuberculosis: an iatrogenic problem.
    Kant S; Maurya AK; Kushwaha RA; Nag VL; Prasad R
    Biosci Trends; 2010 Apr; 4(2):48-55. PubMed ID: 20448341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms of the formation of drug resistance of Mycobacterium tuberculosis (review of the literature)].
    Tungusova OS; Mar'iandyshev AO
    Probl Tuberk; 2001; (6):48-9. PubMed ID: 11641963
    [No Abstract]   [Full Text] [Related]  

  • 4. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 5. [Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs].
    Garzón MC; Angée DY; Llerena C; Orjuela DL; Victoria JE
    Biomedica; 2008 Sep; 28(3):319-26. PubMed ID: 19034356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M; Marjani M; Chitsaz E; Kazempour M; Esmaeili M; Farnia P; Tabarsi P; Amiri MV; Mirsaeidi M; Mansouri D; Masjedi MR; Velayati AA
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the future trend of drug-resistant tuberculosis in Thailand: assessing the impact of control strategies.
    Nishiura H; Patanarapelert K; Tang IM
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):649-56. PubMed ID: 15689082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Shortened, strictly supervised tuberculosis treatment in populations with moderate drug resistance levels: international impact perspective].
    Santos-Preciado JI; Franco-Paredes C
    Rev Invest Clin; 2005; 57(3):488-90. PubMed ID: 16187710
    [No Abstract]   [Full Text] [Related]  

  • 11. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 12. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M
    Tuberkuloza; 1966; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract]   [Full Text] [Related]  

  • 13. [Epidemiological survey on the trend of drug resistance of Mycobacterium tuberculosis complex in Macao during 2001 to 2005].
    Cheong SV; Lao UL
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):411-4. PubMed ID: 17673010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A; Mondal R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.
    Atre SR; Mistry NF
    J Public Health Policy; 2005 Apr; 26(1):96-114. PubMed ID: 15906879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for drug resistant tuberculosis in southeast Turkey.
    Tanrikulu AC; Hosoglu S; Ozekinci T; Abakay A; Gurkan F
    Trop Doct; 2008 Apr; 38(2):91-3. PubMed ID: 18453496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant tuberculosis in Egyptian children using Etest.
    Morcos W; Morcos M; Doss S; Naguib M; Eissa S
    Minerva Pediatr; 2008 Dec; 60(6):1385-92. PubMed ID: 18971899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The rate and pattern of drug resistance in Mycobacterium tuberculosis at various sites of the disease].
    Vishnevskiĭ BI; Steklova LN
    Probl Tuberk Bolezn Legk; 2008; (12):5-8. PubMed ID: 19227317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution in the resistance of Mycobacterium tuberculosis to anti-tuberculosis drugs in Nicaragua.
    Chacón L; Lainez M; Rosales E; Mercado M; Caminero JA
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):62-7. PubMed ID: 19105880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.